Engagement with Care, Substance Use, and Adherence to Therapy in HIV/AIDS

Table 1

Sample demographics.


Gender
Male	455	59.2%
Female	296	38.5%
Transgender	17	2.2%
Age	42.8 years	SD = 9.6 (range 20–72)
Race
Asian/Pacific Islander	11	1.4%
African national and American/black	335	43.6%
Hispanic/Latino	214	27.8%
Native American Indian	8	1.0%
White/Anglo (non-Hispanic)	163	21.2%
Other	37	4.8%
Highest education
Grade school	223	29.1%
High school	318	41.5%
Technical/vocational school	143	18.6%
College	59	7.7%
Master’s	20	2.6%
Doctorate	4	0.5%
# Children at home
0	139	37.9%
1	81	22.1%
2	80	21.8%
3	31	8.4%
>4	36	9.8%
Data Collection Sites
USA (10)
California (3)	107	13.8%
Texas (3)	190	24.5%
Massachusetts (1)	69	9.0%
Utah (1)	69	9.0%
Illinois (1)	16	2.0%
Pennsylvania (1)	107	13.8%
Africa (2)
South Africa (1)	48	6.2%
Kenya (1)	71	9.2%
Puerto Rico (2)
San Juan (1)	70	9.0%
Vega Baja (1)	28	3.6%
AIDS diagnosis
Yes	322	42.0%
No	408	53.2%
Don’t know	37	4.8%
Taking HIV Meds now
Yes	537	70.4%
No	226	29.6%
Other Medical Conditions
Yes	470	62.7%
No	280	37.3%
Years HIV Positive	9.1 years	SD ± 6.6 (Range: 0–26)
Recent CD4 Count (if known)	407	SD ± 268 (Range: 0–1200)
Viral Load “Undetectable”	251	33.4%
Viral Load (Greater than 50 copies/mL) ()	50368	SD ± 135000 (Range: 50–750000)
Years on ARV Medications	6.7 years	SD ± 5.2 (Range: 0–20)